This Ipsos healthcare publication provides a summary review of market opportunities related to universal healthcare programmes in ASEAN – with a special focus on Indonesia, Vietnam and the Philippines. As each country’s population joins its national health system, extensive partnerships are needed to fill the demand for hospital beds, qualified doctors, modern equipment, quality medicine and after-sales service.
This healthcare paper takes an up-to-date look at current needs and priorities within these countries’ healthcare plans, along with an analysis of the relevant budgetary and regulatory issues involved.
Email your questions and comments about this healthcare paper to indonesia.bc@ipsos.com
The main growth driver for Indonesia's fisheries is the fact that key commodities such as fish and shrimp continue to enjoy strong demand domestically and abroad respectively. The main domestic factor is the fact that the archipelago nation of more than 250 million people is a major consumer of fish. Fish consumption per capita was estimated at 33.76 kg / year in 2014. Thanks to wide coastline and warm tropical climate, Indonesia has become one of the top 4 nations in fishery production. Download this publication to read about the opportunities within Indonesia's aquaculture industry.
Email your questions and comments about this complimentary publication to agribusiness@ipsos.com
Information regarding Pestel has been part of market analysis for any industrial sectors especially in countries such as Indonesia of where some industrial data is quite often unavailable. Analyst is compelled to do guesstimation by using limited information.
This condition has quite often placed Pestel data and analysis as one of important information for business analist to do market estimation especially in term of future projection.
Canvassco as one of the regional B2B research agency presents a pestel analysis in an interactive design as market analysis does not have to be boring.
Indonesia: Country Analysis (International Marketing)Rahul Wane
A thorough country analysis of Indonesia with International Marketing point of view. Consists of latest statistics, facts and figures as of 2013-14. Covers points such as Market Potential Index, Hofstede Model, GCI Index, PESTEL and SWOT analysis.
This presentation contains the positive and negative impacts regarding corona. I made it from various resources and wanted it share it publicly, so that others can also use it.
These are slides from an economics revision webinar on aspects of the Indian economy.
Population: 1.3 billion; Urbanization: 33%
Life expectancy: 68 years (average)
HDI ranking 131st/188
Per capita GNI (PPP) $5,663
% living on less than $1.90 a day (PPP) 21%
% of population under-nourished: 15%
Remittance inflow (net) +3.3% of GDP
Gini coefficient: 0.35
Palma Ratio: 1.5
Successful diversification into manufacturing
Globally competitive in many service industries
The main growth driver for Indonesia's fisheries is the fact that key commodities such as fish and shrimp continue to enjoy strong demand domestically and abroad respectively. The main domestic factor is the fact that the archipelago nation of more than 250 million people is a major consumer of fish. Fish consumption per capita was estimated at 33.76 kg / year in 2014. Thanks to wide coastline and warm tropical climate, Indonesia has become one of the top 4 nations in fishery production. Download this publication to read about the opportunities within Indonesia's aquaculture industry.
Email your questions and comments about this complimentary publication to agribusiness@ipsos.com
Information regarding Pestel has been part of market analysis for any industrial sectors especially in countries such as Indonesia of where some industrial data is quite often unavailable. Analyst is compelled to do guesstimation by using limited information.
This condition has quite often placed Pestel data and analysis as one of important information for business analist to do market estimation especially in term of future projection.
Canvassco as one of the regional B2B research agency presents a pestel analysis in an interactive design as market analysis does not have to be boring.
Indonesia: Country Analysis (International Marketing)Rahul Wane
A thorough country analysis of Indonesia with International Marketing point of view. Consists of latest statistics, facts and figures as of 2013-14. Covers points such as Market Potential Index, Hofstede Model, GCI Index, PESTEL and SWOT analysis.
This presentation contains the positive and negative impacts regarding corona. I made it from various resources and wanted it share it publicly, so that others can also use it.
These are slides from an economics revision webinar on aspects of the Indian economy.
Population: 1.3 billion; Urbanization: 33%
Life expectancy: 68 years (average)
HDI ranking 131st/188
Per capita GNI (PPP) $5,663
% living on less than $1.90 a day (PPP) 21%
% of population under-nourished: 15%
Remittance inflow (net) +3.3% of GDP
Gini coefficient: 0.35
Palma Ratio: 1.5
Successful diversification into manufacturing
Globally competitive in many service industries
This reduction in supply along with the support by a number of Government schemes, including MGNREGA has led to an escalation in farm wages which is adversely impacting the profitability of the farmer. Rural wages have been growing by 17% on average since 2006-07 outstripping urban wages. At the same time, the increase in wages, without an increase in productivity, is fueling inflation.
Cover Story Is India's food security bill the magic pill?
Outlook Euro
Stats Currency Composition of Foreign Exchange Reserve
Emerging Country Philippines
In Focus US Becoming a Surveillance State. Right or Wrong?
MEET INDIA - Paris presentation -Mohan Guruswamyavidas
Modern India now has over 2000 ethnic groups. Modern Indian languages have evolved from all the world’s four language families. Indo-European, Dravidian, Austro-Asiatic and Tibeto-Burman. India has 1652 individual mother tongues. 30 languages are spoken by over a million each, and 122 by over 10,000 each.
India has almost 1.2 billion people, and the Union of India consists of 32 States and Union Territories. The biggest of these is Uttar Pradesh with a population of 199.6 million or 16.49% of India’s. It is as big as Brazil. The smallest political unit is Lakshadweep which has just 64,000 (0.01%)
In late 2012 India became the world’s third largest economy in PPP terms and has grown at an average rate of over 7.4% during 2004-14 and GDP from about $750 bn to $2 trl. Between 2008-11 it grew at more than 9%. In consonance with global trends India’s growth also has tapered off these past two years.
Clearly it’s a country of great heterogeneity, complexity and promise. Its diversity makes it unsuitable for any other form of government but a very raucous DEMOCRACY.
ASEAN Macroeconomic Trends_Indonesia Continues to Lower Interest Rates; Vietn...Kyna Tsai
During 16–30 September, amongst the participating countries in ASEAN, the central banks of Indonesia,
Thailand, and the Philippines each held monetary policy meetings, and Indonesia’s second consecutive
decision to lower its interest rates is worth attention. Furthermore, Vietnam exhibited a high real GDP
growth rate for 3Q, recording 7.5%. Please refer to the table attached at the end of this report for an
overview of the macroeconomic indices for ASEAN economies released during 16–30 September.
Indian Economy a key factor for shaping Indian Society and Law: A case of Indian Farmer’s Loan: How Loan Waivers has become a part of Election manifesto and impacts of such loan waivers over Farmers and Indian Economy.
CREATING OPPORTUNITY: How to build a new era of trade for post-Brexit BritainIpsos Business Consulting
The referendum on the UK's membership of the European Union was a pivotal moment for the country. Whilst the uncertainty surrounding the UK's access to the single market has understandably dominated the discussions to date, this is an opportune time to reflect on the strength, depth and history of Britain's trade with the rest of the world and the many trade agreements that facilitate this trading. Change brings with it a degree of uncertainty. But it also brings an opportunity to reshape the growth agenda. As British business looks to pinpoint where the new trade opportunities exist, Ipsos Business Consulting latest industry guide examines some of the developed and emerging markets that offer evolving opportunities for British business.
Email your comments and questions about this trade report to brexit.support@ipsos.com
With Korea acting as a fast follower rather than an innovator in the 3D printing industry, Korean companies are now setting their sights on catching up to the field in this quickly developing sector. In this Ipsos publication, we review the Korean 3D printing industry in its present state, including its most promising opportunities as well as the barriers to success that business is currently facing. We then put a special focus on the major Korean players, the parts of industry where the technology is most likely to take hold in the coming years, and how the government and businesses are stepping up to the challenge. The Ipsos publication includes:
- Market Potential of the Korean 3D Printing Industry
- Barriers to Growth in the Korean 3D Printing Industry
- Detailed Trends of the Korean 3D Printing Industry, by Sector
- 3D Printing in the Education and Health Sectors within Korea
- Korean Government Policies for 3D Printing
- Government Investment in Korean 3D Printing Industry
- Future Prospects for the Korean 3D Printing Industry
Email your questions and comments about this Ipsos paper on the developments in Korean 3D Printing paper to korea.bc@ipsos.com
This reduction in supply along with the support by a number of Government schemes, including MGNREGA has led to an escalation in farm wages which is adversely impacting the profitability of the farmer. Rural wages have been growing by 17% on average since 2006-07 outstripping urban wages. At the same time, the increase in wages, without an increase in productivity, is fueling inflation.
Cover Story Is India's food security bill the magic pill?
Outlook Euro
Stats Currency Composition of Foreign Exchange Reserve
Emerging Country Philippines
In Focus US Becoming a Surveillance State. Right or Wrong?
MEET INDIA - Paris presentation -Mohan Guruswamyavidas
Modern India now has over 2000 ethnic groups. Modern Indian languages have evolved from all the world’s four language families. Indo-European, Dravidian, Austro-Asiatic and Tibeto-Burman. India has 1652 individual mother tongues. 30 languages are spoken by over a million each, and 122 by over 10,000 each.
India has almost 1.2 billion people, and the Union of India consists of 32 States and Union Territories. The biggest of these is Uttar Pradesh with a population of 199.6 million or 16.49% of India’s. It is as big as Brazil. The smallest political unit is Lakshadweep which has just 64,000 (0.01%)
In late 2012 India became the world’s third largest economy in PPP terms and has grown at an average rate of over 7.4% during 2004-14 and GDP from about $750 bn to $2 trl. Between 2008-11 it grew at more than 9%. In consonance with global trends India’s growth also has tapered off these past two years.
Clearly it’s a country of great heterogeneity, complexity and promise. Its diversity makes it unsuitable for any other form of government but a very raucous DEMOCRACY.
ASEAN Macroeconomic Trends_Indonesia Continues to Lower Interest Rates; Vietn...Kyna Tsai
During 16–30 September, amongst the participating countries in ASEAN, the central banks of Indonesia,
Thailand, and the Philippines each held monetary policy meetings, and Indonesia’s second consecutive
decision to lower its interest rates is worth attention. Furthermore, Vietnam exhibited a high real GDP
growth rate for 3Q, recording 7.5%. Please refer to the table attached at the end of this report for an
overview of the macroeconomic indices for ASEAN economies released during 16–30 September.
Indian Economy a key factor for shaping Indian Society and Law: A case of Indian Farmer’s Loan: How Loan Waivers has become a part of Election manifesto and impacts of such loan waivers over Farmers and Indian Economy.
CREATING OPPORTUNITY: How to build a new era of trade for post-Brexit BritainIpsos Business Consulting
The referendum on the UK's membership of the European Union was a pivotal moment for the country. Whilst the uncertainty surrounding the UK's access to the single market has understandably dominated the discussions to date, this is an opportune time to reflect on the strength, depth and history of Britain's trade with the rest of the world and the many trade agreements that facilitate this trading. Change brings with it a degree of uncertainty. But it also brings an opportunity to reshape the growth agenda. As British business looks to pinpoint where the new trade opportunities exist, Ipsos Business Consulting latest industry guide examines some of the developed and emerging markets that offer evolving opportunities for British business.
Email your comments and questions about this trade report to brexit.support@ipsos.com
With Korea acting as a fast follower rather than an innovator in the 3D printing industry, Korean companies are now setting their sights on catching up to the field in this quickly developing sector. In this Ipsos publication, we review the Korean 3D printing industry in its present state, including its most promising opportunities as well as the barriers to success that business is currently facing. We then put a special focus on the major Korean players, the parts of industry where the technology is most likely to take hold in the coming years, and how the government and businesses are stepping up to the challenge. The Ipsos publication includes:
- Market Potential of the Korean 3D Printing Industry
- Barriers to Growth in the Korean 3D Printing Industry
- Detailed Trends of the Korean 3D Printing Industry, by Sector
- 3D Printing in the Education and Health Sectors within Korea
- Korean Government Policies for 3D Printing
- Government Investment in Korean 3D Printing Industry
- Future Prospects for the Korean 3D Printing Industry
Email your questions and comments about this Ipsos paper on the developments in Korean 3D Printing paper to korea.bc@ipsos.com
To explore perceptions, Ipsos conducted a survey amongst a representative sample of more than 1000 Australians, which revealed that most people understand little about the range of technologies that fall under the AI banner and what they do know is informed by Hollywood — ‘the Terminator effect,’ if you like.
3D Printing: The genesis of a new realm of possibility in manufacturing and s...Ipsos Business Consulting
3D Printing is a powerful technology that some are describing as revolutionary. Whilst many industrial manufacturers have been slow to adopt the technology, the number of companies adapting their manufacturing process and supply chains is expected to increase as the materials that can be used in 3D printing expand and the speed of printing improves: there are already reports of US research labs creating 3D printers that work at speeds of 5-6 times that of existing commercial 3D printers. This industry guide from Ipsos Business Consulting looks at the potential developments in industrial manufacturing with a spotlight on China, India and the ASEAN countries.
Email your questions and comments about this complimentary publication to industrial@ipsos.com
Indonesia, the Philippines, and Vietnam, which have led regional growth in healthcare over the past three years because of their on-going universal healthcare programmes, exhibit some of the sector’s strongest near-term potential within the region.
For more information, please contact consulting.bc@ipsos.com
Despite the relatively stable growing trend over the past few years, meat output has not managed to keep up with the consumption demand. Whilst domestic pork production is relatively sufficient for the domestic consumption demand, there is a significant shortage in the supply of beef and chicken.
For more information, please email vietnam.bc@ipsos.com
Indonesia’s DC construction market is expected to grow by 11.4% a year between now and 2020, supported by the expansion of colocation and managed hosting services provided by key DC suppliers to both large enterprises and SMEs.
For more information, please email indonesia.bc@ipsos.com
Special thanks to Singapore Economic Development Board for quoting us in one of the featured articles.
ASEAN millennials are fortunate in having been born in the best of times for the SE Asia region. Businesses are adapting their marketing messages and hiring processes to attract their loyalty.
Read more here http://bit.ly/ASEANmillennials
How can health accounts inform health sector investments? Lessons from countr...HFG Project
Countries must have a firm grasp on their health financing landscape in order to ensure sufficient and effective use of resources. Health Accounts—an internationally standardized methodology that allows a country to understand the source, magnitude, and flow of funds through its health sector—provide a wealth of information on past spending. When combined with macroeconomic, health utilization, and health indicator data, Health Accounts provide powerful insights for health financing policy.
USAID’s Health Finance and Governance (HFG) project supports countries to institutionalize their Health Accounts so that they are produced regularly and efficiently, and are a useful tool for policymakers. In this technical briefing webinar, held June 29, 2016, HFG experts used country examples to demonstrate how Health Accounts have been (and can be) used to inform national health financing decisions. The experts also provided perspectives on the future of Health Accounts.
Amid a general slowdown of the global pharmaceutical market, pharmerging markets continue to be a formidable engine of growth; across Asia, Africa and South America, these markets are boasting a CAGR of 10-14%. At the outer edges of these growing economies are markets identified by IMS Health as “Frontier Markets” – the next big drivers of growth, opportunity and even innovation.
Among the Frontier Markets, Myanmar is capturing the most attention. With the completion of parliamentary elections in early November of 2015, there are positive signs that the momentum for change and market liberalization will accelerate. Indeed, Myanmar resembles the early days of some of today’s leading Asian developing markets such as Vietnam and Indonesia. However, while understanding the similarities is certainly valuable, the temptation to merely duplicate entry strategies and market assumptions should be resisted. Myanmar’s underinvested healthcare infrastructure, sizeable talent gaps, and significant regulatory and affordability hurdles, require an informed approach, and managed expectations. Multinationals will be challenged to re-evaluate what it takes to play, and what it means to win in both the short and long term.
An introductory overview of healthcare across South East Asia and a look at the growing healthcare trends across the region.
Download the presentation by clicking the "Save this presentation" icon above.
Healthcare system being a priority in the world.Also, healthcare systems in low middle income countries should draw attention especially with the world witnessing global pandemic, COVID-19.
While growth has picked up, more needs to be done for Japan to overcome two key challenges – a record high government debt ratio and an accelerating decline in its working-age
population.
Presented at “Financial Protection and Improved Access to Health Care: Peer-to-Peer Learning Workshop Finding Solutions to Common Challenges” in Accra, Ghana, February 2016. To learn more, visit: https://www.hfgproject.org/ghana-uhc-workshop
Universal Health Coverage and Health Insurance - IndiaDr Chetan C P
Presentation is a case about cutting the risk fragmentation and having a universal pool for Health Insurance as one of the tools for achieving UHC in India.
'The Digital Healthcare Leap' highlights insights into how digital health could be an answer to the emerging markets’ challenge to achieve sustainable growth; and leapfrog the developed nations to provide quality, affordable, universal and patient-centric care.
With increased internet and smartphone penetration, and the arrival of new affordable technological solutions in the market, digital healthcare will eventually become a fundamental business imperative. The challenge to healthcare providers for the future, is to adapt and set strategies that leverage new technology while putting patients at the heart of everything they do.
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...Office of Health Economics
This presentation looks at rates of GDP spend on health care, distinguishing between categories of country (i.e. levels of GDP pre capita). It looks at the relationship between rates of spending and moves to universal health coverage, and explores alternative ways of increasing expenditure and making decisions about which services to provide with the money available.
There are numerous changes taking place in South Africa, in the economy, politics and health. All these are interdependent and embedded in a social milieu which brings a number of pressures on health services and systems. The major event in the medium to long term is the impact of the National Health Insurance. Other contextual factors of importance include the range of social determinants of health and disease, with the provision of water, sanitation, electricity and housing being the key services. South Africa will also be influenced in the future by the major diseases it harbours at present. This seminar provided some insight into how these factors will impact on the South African Health Services.
Similar to Identifying Opportunities Within ASEAN’s Universal Healthcare Programmes (20)
At a time when technology has the potential to change the way we travel, this new white paper reveals global consumer attitudes towards the prospect of fully automated cars.
Obesity is the third greatest social burden driven by human beings, after smoking and war, violence and terrorism. And while sugar consumption is far from the only cause of this, it is increasingly in the spotlight.
Foot on the Pedal - Opportunities Fuelled by a Booming ASEAN Automotive IndustryIpsos Business Consulting
ASEAN is one of the world’s fastest-growing markets, and has all the right elements for a robust automotive sector.
For more information, please email consulting.bc@ipsos.com
This presentation from the Ipsos automotive consultants in Korea covers:
- Domestic production sales
- Export to overseas markets
- Future technology such as connected cars, autopilot, eco-friendly cars etc
Email your questions and comments about the papers contents to korea.bc@ipsos.com
***NOTE: An English language translation of this presentation can be obtained by emailing korea.bc@ipsos.com, quoting "KAMA presentation"
Global lubricant markets have seen a dramatic rebound since the global economic recession of 2008–2009. At that time, global demand dipped to its lowest point since the latter half of the 20th century, but has since surpassed its previous high mark set in 2007. One of the key drivers of this rebound can be attributed to Asia, where the developing economies of emerging markets are fueling the rising demand for lubricants. ASEAN is an association of 10 member countries located in South East Asia. This new Ipsos paper explores the future growth potential in the region's lubricant industry.
Email your questions and comments about this complimentary publication to asean@ipsos.com
China overtook the United States as the world’s largest automotive market in 2009 and has retained the crown since then. China’s automotive aftermarket industry value reached USD 118 billion in 2015 and it is expected to grow at 12.7% CAGR to reach USD 214 billion by 2020. The average age of vehicles in China is expected to reach 5.0 years by 2018. As in developed countries, the Chinese automotive aftermarket will experience a boom once average vehicle age exceeds 5 years. This automotive industry guide takes a look at the realities and trends of the automotive aftersales market in China and sets out some of the opportunities and challenges that automotive companies, auto part makers and aftersales service providers will encounter when looking to secure high performance.
Email your questions and comments about this complimentary report to china.bc@ipsos.com
过去十年,中国汽车后市场销售额已从2005年的880亿元增至2015年的7700亿元;而预计至2020年,这个市场将扩张至万亿元体量。中国汽车后市场潜力无限,但竞争格局却复杂多变。在最新的汽车后市场白皮书中,我们的汽车团队分析了2016年中国汽车后市场的发展现状及前景展望,包括OEM汽车厂商和零部件制造商需如何面对未来市场的机遇和挑战。益普索报告具体着眼于:
- 中国汽车后市场整体发展及未来趋势
- 中国汽车后市场新兴商业模式和多样化分销渠道
- 中国汽车后市场独立渠道的快速发展和未来趋势
Email your questions and comments on the report contents to china.bc@ipsos.com
Indonesia’s developing used car market is gradually becoming more structured due to the greater availability of flexible financing terms, standardized and authorized dealership channels and better transparency of information. Significant opportunities exist for Indonesia’s growing aftermarket landscape, with over 11 million PVs (~77% of total PV population) to be out of warranty by 2020, with an out of warranty population CAGR of 9.7% from 2015-2020. In our latest industry guide we explore the Implications for foreign and new market players seeking to capture Indonesia’s aftermarket opportunity.
Email your questions and comments about the contents to indonesia.bc@ipsos.com
ASEAN is host to two of the world's most important emerging markets for Automotive - Thailand and Indonesia. In this complimentary automotive publication our Automotive team in Jakarta provide you with an outlook on the Indonesian automotive industry in 2020, including the opportunities and challenges that automotive OEMs and parts manufacturers will need to address. Specifically, the Ipsos paper looks at:
- Indonesian Passenger Vehicle and Motorcycle Market Trends
- Indonesian Commercial Vehicle Market Trends
Email questions or comments on the contents to: indonesia.bc@ipsos.com
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...The Lifesciences Magazine
Cold Sores, medically known as herpes labialis, are caused by the herpes simplex virus (HSV). HSV-1 is primarily responsible for cold sores, although HSV-2 can also contribute in some cases.
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessFitking Fitness
"Feature:
• Intelligent Ergonomically Design Glute Builder Is A Must Have For Those Looking To Target Their Gluteal Muscles And Hamstrings With Precision.
• The Ability To Adjust The Starting Position, This Machine Allows For A More Targeted Workout That Is Tailored To Your Specific Needs.
• Spacious And Supportive Cushioned Seat Provide Added Comfort And Stability During Your Workout."
Get more information visit on:- www.fitking.in
Our mail I.D:-care@fitking.in, fitking.in@gmail.com
Call us at :- 9958880790, 9870336406, 8800695917
Letter to MREC - application to conduct studyAzreen Aj
Application to conduct study on research title 'Awareness and knowledge of oral cancer and precancer among dental outpatient in Klinik Pergigian Merlimau, Melaka'
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
3. INTRODUCTION
The strong growth potential of emerging economies, such
as those within the Association of Southeast Asian
Nations (ASEAN), continues to attract attention from
global businesses. Combined, the 10 member states —
Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the
Philippines, Singapore, Thailand and Vietnam — account
for almost 9% of the global population with the grouping’s
annual economic growth expected to remain relatively
high, at about 7%, by 2020, outpacing many other countries
and regions.
Indonesia, the region’s largest economy and most populous
nation, accounts for 38% of Asean’s economy and 40% of
its population. It is among the world’s 15 most populous
countries, along with the Philippines and Vietnam, which
are respectively expecting to achieve economic growth of
7.6% and 11.1% a year until 2020. Singapore, Thailand and
Malaysia posted a combined gross domestic product (GDP)
of about US$980.97bn in 2015 with expected annual
growth ranging from 5.0–11.7% by 2020. Annual economic
growth looks positive in other Asean economies and is
expected to exceed 8% a year in Brunei, Laos, Cambodia
and Myanmar within the same period.
The Philippines and Vietnam are among the fastest-growing
Asean economies. The Philippines government has spurred
economic growth through infrastructure development
which has improved job opportunities and increased
household spending. Vietnam has signed trade agreements
with EU countries, which are expected to fuel further
growth.
Ipsos Business Consulting Identifying Opportunities Within Asean’s Universal Healthcare Programmes | 3
7,204.96
7,630.98
CAGR:
1.2%
CAGR:
1.0%8.7%
ASEAN
91.3% 91.3%
8.7%
Non-ASEAN
World population (millions), 2015–20
Source: IMF World Economic Outlook Database
Global and Asean gross domestic product (USD, billions)
2015–20
73,192.5
95,332.4
CAGR:
7.8%
CAGR:
5.3%
96.6%
2015 2020f
ASEAN
3.4%
3.7%
96.3%
Non-ASEAN
Source: IMF World Economic Outlook Database
2015 2020f
4. HEALTHCARE IN ASEAN’S EMERGING
COUNTRIES
Improving economic development across Asean is driving
the healthcare industry’s development. Singapore,
Thailand and Malaysia have benefited from the rise of
global medical tourism which supports quality healthcare
facilities, medical professionals, hospitality and related
services. Other Asean countries have started implementing
universal healthcare policies to support local demand for
higher quality affordable treatment, as well as to fulfil UN
Sustainable Development Goals by 2030. Laos and Cambodia
have partially implemented universal healthcare covering
about 12% and 17% of their populations respectively.
Myanmar is also making steps towards universal coverage
with its Myanmar Health Vision 2030.
Indonesia, Vietnam and the Philippines, which have led
regional growth in healthcare over the past three years
due to their on-going universal healthcare programs,
exhibit some of the sector’s strongest near-term potential
within the region
Analysis of key market and healthcare indicators among
Asean countries
Source: Ipsos Business Consulting Analysis
Healthcare Service
MakretPotential
Low
Cambodia
Myanmar
Philippines Vietnam
Indonesia
Malaysia
Thailand
Singapore
Brunei Darussalam
Laos
Low
Med High
High
Key comparative indicators for healthcare market potential
within Asean
Sources: IMF World Economic Outlook Database, World Bank, UN
GDP per
Capita, 2015
% of Aged
Population, 2015
Population Size,
2015 In mn
Expected
GDP Growth,
2015-2020f
Expected Ageing
Population Growth,
2015-2020f
$3,416
$2,951
6.5%
11.1%
255.5
101.4
6.7%
5.6%
4.6%
3.4%
5.2%
4.6%91.6
7.6%
$2,171
Indonesia PhilippinesVietnam
Key comparative indicators for healthcare development
Sources: BMI Report on Pharmaceutical and Healthcare Report, government health data for
each country, World Bank
Healthcare
Expenditure
per Capita 2015
Hospital Bed per
1000 Population,
2015
Expected
THE Growth,
2015-2020f
Total Healthcare
Expenditure
(THE) in 2015, in
USD bn
Doctors / Physicians
per 1,000 population,
2015
$95.9
$137.0
$24.5
$13.9
10.2%
9.3% 2.5
0.3
0.7
0.81.2
0.8
8.4%
$12.0
$131.0
Indonesia PhilippinesVietnam
Ipsos Business Consulting Identifying Opportunities Within Asean’s Universal Healthcare Programmes | 4
5. The three countries are also expected to see growth in
their elderly populations at about the same annual rate as
the general population, which is forecast to rise by 3-5%
a year until 2020. The incidence of chronic diseases and
healthcare expenditure will also increase as these societies
continue to age. These trends, supported by the gradual
implementation of universal healthcare policies and the
development of healthcare infrastructure, are forecast to
see Indonesia, the Philippines and Vietnam post the
strongest growth in total healthcare expenditure, ranging
from 8–10% a year by 2020.
Theshortageandunevendistributionofmedicalprofessionals,
a low per-capita ratio of hospital beds, and relatively high
out-of-pocket healthcare expenses are key challenges for
the industry across the three countries. National health
insurance will play a critical role in facilitating access to
healthcare and reducing out-of-pocket expenses.
Thailand provides a strong regional example of these
benefits. Within a year of implementing its universal
healthcare programme in 2002 it reduced out-of-pocket
expensesfrom21.5%toabout8%oftotalhealthexpenditure.
Current out-of-pocket expenses in Indonesia, the Philippines
and Vietnam provide a stark contrast, accounting for 36%
to 54% of total healthcare expenditure in 2014 despite the
gradual rolling out of universal health coverage.
Percentage of out-of-pocket expenses from total healthcare expenditure, 2004–14
Source: World Bank
10
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
0
20
30
40
50
60
70
VNM THA IDN PHL
Ipsos Business Consulting Identifying Opportunities Within Asean’s Universal Healthcare Programmes | 5
6. Target of Coverage • Full population coverage by 2017• Full population coverage by 2019 • 80% of population covered by 2020
Benefits and
Services Package
• Benefits are classified into four
types:
o Inpatient benefits – including 11
medical and 12 surgical cases
o Outpatient benefits – including
day surgery, radiotherapy,
haemodialysis, outpatient blood
transfusion, MDG related, and
primary care
o Z Benefits – for chronic cases,
such as cancer, acute leukaemia,
orthopaedic implants
• Same benefits package across all SHI
members:
o Inpatient / outpatient care and
medical rehabilitation (including
antenatal care and birth)
o Disease screening
o Drug reimbursement for
medicines listed by Ministry of
Health
o Travel expenses from district to
higher-level hospitals (for
particular groups)
Schemes &
premiums
• Six membership categories:
o Formal economy (private,
government, household help,
enterprise owners) Premium
based on earnings, totalling 2.5%
of income split equally between
employer and employee
o Informal economy (migrant
workers, informal sector, self
employed individual, organised
groups) – premium for monthly
income <P25,000 at P600/quarter
and >P25,000 at P900/quarter
o Indigents (insufficient income for
family subsistence) – government
fully subsidises premiums.
o Sponsored – premium is
subsidised from sponsoring
individual/local government/
organization
o Senior citizens – premium free as
it is paid from Sin Tax Law as per
Republic Act No. 10351
o Lifetime – Non-paying after 120
monthly contributions aged >56
years old
• Five membership groups:
o Employers and employees:
(> 3 months’ work contract) –
4.5% of income, split by 3%
employer and employee 1.5%
o Social Insurance Authority
recipients – including pensioners,
injured workers, unemployed
o People paid from the state
budget: including civil servants,
soldiers, war veterans, ethnic
minorities, low-income earners,
and children under six years
o People supported by the state
budget: Households living just
above the poverty line and
students – Premium subsidy of
70% to the near poor and 30% to
students
o SHI household members
(including family members, not
classified under another group)
Inception
• The National Health Insurance Act
in 1995 or Republic Act 7875,
established PhilHealth to
implement the NHIP with a
mandate to provide full coverage
within 15 years of its inception
• Healthcare coverage went through
many transformations from 1960
to 2014
• From 1st January 2014, JKN is
operated though a single provider,
BPJS. Previously health insurance
wasmanaged under PT. ASKES
• Introduced in 1992 under Decree
No. 299/1992/HDBT
• The separate Health Care Fund for
the Poor (HCFP) was introduced in
2003 and merged with the national
insurance programme in 2009
• The law was revised in 2015 to
make the enrolment of all
households compulsory
Provider
• Philippines Health Insurance
Corporation (PhilHealth)
• Social Security Agency for Health or
Badan Penyelenggara Jaminan
Sosial - Kesehatan (BPJS Kesehatan)
• Vietnam Social Security Agency
(VSS)
Policy
Indonesia The Philippines Vietnam
• Philippines’ National Health
Insurance Programme (NHIP)
• Jaminan Kesehatan Nasional (JKN),
or Indonesia’s National Health
Insurance
• Bao Hiem Y Te (BHYT), or Vietnam’s
Social Health Insurance (SHI)
Source: Ipsos Business Consulting Analysis
NATIONAL INSURANCE IN INDONESIA, THE PHILIPPINES AND VIETNAM
Overview of universal healthcare schemes1
• BPJS covers 155 types of disease at
the primary healthcare level
• Around 700+ cases are code listed
in the Indonesia Case Based Group
depending on region, hospital class,
and type of treatment (inpatient/
outpatient)
• BPJS covers some 574 types of drugs
through the 2016 National
Formulary for 29 therapeutic classes
and 90 sub-therapeutic classes
• Two categories, including foreign
workers who stay a minimum six
months:
o Low-income members (PBI) – IDR
23,000 a month, paid by the
government
o Non-PBI member:
Salaried workers & families
(PPU) – premium at 4.5% from
income, split 4% byemployer
and 0.5% by employee.
• Civil servants, soldiers, police,
government officials and staff
• Labour (state-owned and
private)
Non-salaried workers & families
(PBPU), including self-employed,
non-contracted workers –
premium at IDR 25,500 for class
III, IDR 51,000 for class II, and IDR
80,000 for class I per member/
month
Non-workers & families (BP),
including veterans, investors, etc)
– 5% from 45% of civil servant’s
basic
Ipsos Business Consulting Identifying Opportunities Within Asean’s Universal Healthcare Programmes | 6
7. CURRENT PROGRESS
The Philippines and Vietnam have already covered more
than 70% of their populations with their respective
programmes. Vietnam began compulsory registration of
households in 2015 in line with its revised Health Insurance
Law. A healthcare data portal and information system for
verifying eligibility for health insurance was introduced in
its hospitals the following year to reduce the cost and time
of servicing socially insured patients.
Indonesia has made good progress with its universal
health insurance, launched after the Philippines and
Vietnam, with coverage rising from 46.7% of the population
in 2013 to 65.4% in 2016. The country passed the Indonesian
Constitutional Law No.24 in 2011 making it compulsory
for all Indonesian citizens to enrol with the national
healthcare scheme which became operational on 1
January 2014. Efficient application procedures, including
an online portal and more than 120 BPJS branches, helped
facilitate Indonesia’s faster enrolment rate compared with
the Philippines and Vietnam.
A prime objective of social health insurance is to ensure
low-income families have access to affordable healthcare.
This is especially important in countries, such as Indonesia
and the Philippines, where a significant proportion of the
population is poor.
Population (%) covered by universal health insurance 2013–161
Sources: Ipsos Business Consulting Analysis, IMF Data, PhilHealth, BPJS
Indonesia
46.7%
49.4%
60.6%
65.4%CAGR = 13.4%
2013 2014 2015 2016
Philippines
78.9%
86.7% 88.2%
89.5%
CAGR = 6.4%
2013 2014 2015 2016
Vietnam
68.9%
71.0%
75.3%
77.0%CAGR = 4.9%
2013 2014 2015 2016
Ipsos Business Consulting Identifying Opportunities Within Asean’s Universal Healthcare Programmes | 7
8. Indonesia launched its programme with a focus on low-
income families (PBI), private large, small, and medium
enterprises, state-owned enterprises, micro businesses,
and non-salaried workers (PBPU and BP). The government
did not achieve its target of covering self-employed,
unemployed and retiree (PBPU and BO) members by the
end of 2015. Enrolling salary earners (PBI and PPU) has
become more efficient as the government imposes strict
penalties on employers who do not enrol employees in
the scheme. PBPU and BP members currently account for
14% of current membership.
Expanding coverage has taken longer in the Philippines,
where PhilHealth was launched in 1995 with coverage
reaching 50–60% between 2001–05. The country’s
informal economy has proven a particularly challenging
segment as self-employed people account for more than
40% of the total workforce. Many employed people do not
have spending priorities.
Before Vietnam made its national health insurance universal
and compulsory in 2015, it had started smaller-scale initiatives
with civil servant and state enterprises in 1992. These
were expanded from 2005 to include non-state enterprises,
poor people and war veterans. Children under six years
old, those living just above the poverty line, and students
and farmers were bought into the scheme from 2009. By
2011, the near poor and poor accounted for 27% of the
membership, followed by students (20%), children under
six years old (15%) and others (38%), health ministry
figures show. Vietnam expanded coverage to 70% of the
population within 2014 after dependents of labourers and
cooperative members were included. Certain sectors, such
as the informal sector and the remaining 40% of private
companies who have yet to enrol their staff, will impede
achieving targeted total coverage due to competing cost
priorities and weaker benefits from coverage for those
people compared with other beneficiaries.
To improve implementation, each country has strived to
build partnerships with private hospitals as inadequate
supply and infrastructure meant government hospitals
were unable to satisfy demand for universal healthcare.
Indonesia’s BPJS formed partnerships with 1,866 hospitals
(about half of which were private) and 25,828 doctors and
healthcare professionals by October 2016. However, the
ratio of health insurance members per hospital remains
very high. In Indonesia, primary healthcare providers refer
patients to higher-level facilities. Stricter referral
mechanisms from primary healthcare providers are
therefore required to prevent overcrowding at the
secondary and tertiary levels. Furthermore, only 64% of
hospitals with the potential to join the universal healthcare
programme have become official partners due to the strict
accreditation policy.
Partner hospitals (as % of total hospitals) and members
served in 2016
Sources: Ipsos Business Consulting Analysis, PhilHealth, BPJS, Desk research
% of hospitals already
partnered
Philippines
Vietnam
Indonesia
Covered Members per
Partnered Hospitals
73% 93,723
64%
87% 60,130
77,316
Indonesia
Philippines
National health insurance membership by group
(2014 and 2015)
Sources: Ipsos Business Consulting Analysis, PhilHealth, BPJS, Desk research
64.8%
18.2%
6.8%
3.7%
ASKES(Transition)
6.6%
24.2%
9.4%
3.2%
2014 2015
63.2%
Formal
Economy
Informal
Economy
Indigents
Sponsored
Senior Citizen
Lifetime
2014 2015
30%
9%
49%
2%
8%
2%
36%
9%
40%
2%
10%
3%
PBI
PPU
PBPU
BP
Ipsos Business Consulting Identifying Opportunities Within Asean’s Universal Healthcare Programmes | 8
9. PhilHealth has also continued to increase its accredited
hospitals from 1,061 at the beginning of 2015 to 1,198 within
the first-half of 2016. By mid-2015, PhilHealth had contracted
17 facilities to deliver its so-called “Z packages” for severe
diseases. However, despite increasing the number of
healthcare facilities within the scheme, the Philippines faced
similar challenges to Indonesia with regards to the number
of national insurance members per participating hospital.
Vietnam, on the other hand, demonstrates much higher
levels of government cooperation with hospitals than
Indonesia or the Philippines. This has resulted in a better
ratio of covered members per hospital. The Vietnamese
government also plans to build more facilities outside of the
Ho Chi Minh and Hanoi regions, as well as increasing the
numberofmedicalpractitionerswithintheprogramme.The
country still needs to be more vigilant in two areas, however:
First, implementing stricter referral mechanisms to enforce
the requirement for members to first contact community
health centres for assessment, these centres will refer them
tohigherlevelfacilitiesifneeded.Currently,manypeoplego
directly to the higher healthcare facilities which means they
are not entitled to full benefits. Second, the Social Security
Agency should control the current fee-for-service payment
systemtoensurequalityofserviceisnotsacrificedforquantity.
Vietnam has generated a significant surplus in terms of the
volumeofpremiumscollectedcomparedwithhealthcare
expenditure even as the country has made great steps in
expanding its coverage. The government plans to provide
healthcare services and high-quality medicine to all
beneficiaries as part of its efforts to promote social equality.
To prevent future problems regarding reimbursement for
fee-for-service payments, Vietnam has established “diagnostic
relatedgroup”(DRG)benchmarksforreimbursementtariffs,
which make it difficult for hospitals to increase patient costs
by adding unnecessary treatments.
The Philippines has also created a slight premium surplus,
despite having the lowest premiums as a percentage of
healthcare expenditure of the three countries. PhilHealth
claims to have a robust financial position for funding its
expanding coverage and payments as fund reserves grow
steadily, despite critics doubting the programme’s
sustainability. Indonesia is in a much weaker position as
benefit payments have exceeded revenues for the past two
years. BPJS relies on investment funds and support from
central government to mitigate premium deficits. However,
the significant rise in benefit payments is positive for the
healthcare industry as they benefit pharmacies, hospitals
andtheirrelatedsupplychains.TheIndonesiangovernment
in early 2016 increased premiums to reduce the scheme’s
rising cost burden.
Comparison between collected premiums and benefit payments
in Indonesia, the Philippines and Vietnam, 2014–15
Premium
Collected
IDR 51.4tn
Benefit
Payment
IDR 56.3tn
Premium
Collected
IDR 39.6tn
Benefit
Payment
IDR 41.3tn
20152014
Premium
Collected
P103 bn
Benefit
Payment
P97 bn
Premium
Collected
P81.4 bn
Benefit
Payment
P78.2 bn
20152014
PHILIPPINES
Sources: PhilHealth, BPJS, Vietnam Ministry of Finance, Vietnam Social Security
Premium
Collected
VND145.9 bn
Benefit
Payment
VND101.2 bn
Premium
Collected
VND130.5 bn
Benefit
Payment
VND 86.3 bn
20152014
VIETNAM
Ipsos Business Consulting Identifying Opportunities Within Asean’s Universal Healthcare Programmes | 9
10. Indonesia’s government launched a new policy in 2016
through Ministry of Health Decree 64/2016 enabling JKN
inpatients to improve their treatment class by paying the
difference in costs for a better room while the treatment,
drugsandequipmenttariffsremainthesame.Thismechanism
negatively affects hospitals, especially private facilities, as
they have to adjust internal calculations where the level
of inpatient class previously referred to different levels of
equipment, medical practitioner fees, and sometimes
drugs. Some of hospitals are now reluctant to continuing
partnering BPJS as a result. This policy could threaten the
relationship between BPJS and facilities, ultimately lowering
levels of access and treatment for patients and members.
Despite the challenges and current issues, national
healthcare insurance programmes present an opportunity
to sustainably deliver affordable healthcare services. The
keytosuccessiscollaborationandsynergyamongstakeholders
while creating the mechanisms to address the needs and
interests of each player. For businesses looking to expand
within the region, it is worth noting that while Indonesia
JKN programme offers strong opportunities due to its
relatively low level of development, significant risks could
emerge as the programme’s mechanisms and regulations
change.
Indonesian BPJS patient visits to healthcare facilities
surged by almost 70% in 2015, driven mostly by outpatient
visits which increased most significantly at secondary and
tertiary healthcare facilities. These figures show how the
programme’s benefits are amplified when access to primary
healthcare facilities rises. Despite the lower proportion of
inpatient cases at secondary and tertiary facilities, these
centres accounted for 55% of total benefit payments in
2014. Attempts to control costs by imposing set fees per
patient (‘capitation’) have not been entirely successful,
and further changes in this area might be expected. With
regards to the payment methods in secondary and tertiary
facilities, the government needs to continue performing
periodic reviews to ensure treatment costs are sustainable
at public and private hospitals while ensuring new diseases
are covered.
BPJS benefit payments by healthcare facilities, 2014
BPJS patient visits to healthcare facilities, 2014-15
Source: BPJS Kesehatan
Source: BPJS Kesehatan
Promotive & Preventive
Non-capitation/CBG Services
Inpatient - Secondary / Tertiary HC
Outpatient - Secondary / Tertiary HC
Outpatient - Primary HC (Capitation)
Inpatient cases - Seondary
/ Tertiary HC
Outpatient - Secondary
/ Tertiary HC
Outpatient - Primary HC
19.6%
2014
2014 2015
16.2%
55.2%
8.7%
0.3%
70.8%
24.4%
68.6%
27.1%
63%
4.3%
87.2 mn 146.7 mn
4.8% 87%
50%
Ipsos Business Consulting Identifying Opportunities Within Asean’s Universal Healthcare Programmes | 10
11. KEY TAKEAWAYS WHAT IPSOS BUSINESS CONSULTING
CAN DO?
1. Clear market segmentation is crucial
With the ongoing implementation of national schemes,
market players need to accurately determine the most
favourable target segments. National programmes boost
access to healthcare especially for the middle-low patient
segment. Additionally, increasing income and improving
health awareness will drive demand in the private sector.
However, the nature of the opportunity for each segment
varies greatly by country.
2. Regional disparity affects patient outcomes
Indonesia, Vietnam, and Philippines face similar problems
from shortages of healthcare practitioners. The level of
healthcare facilities and medical practitioners, not to mention
the type of diseases, also determines the types of medical
devices or equipment needed. These factors vary within
each country’s region, affecting patient needs, treatment
programmes and opportunities for healthcare businesses.
3. Partnership with industry stakeholders is critical for
understanding the evolving market landscape
Government and related bodies must continually evaluate
how well they are implementing their respective national
healthcare programmes, all of which are still in fairly early
stages of development. Such evaluations will inevitably
affect procurement mechanisms. Building and maintaining
strong relationships throughout the stakeholder chain will
improve the flow of reliable information regarding market
dynamics which will be critical in enabling market players
to develop effective strategies.
4. Expanding healthcare market will increase competition
Direct and indirect factors will continue to grow the
region’s healthcare industry and attract new market
entrants. Identifying unmet needs, including technical
factors such as product distribution and after-sales service,
will help market players compete and expand their target
segments.
• We can help you analyse the market, competitive landscape
and customer behaviour to deliver insights into which
market you should target and how you should target it.
• We can also assist you in predicting future developments,
as well as likely business impacts, so you can determine
favourable growth strategies
We are the market intelligence and strategy division of
Ipsos. Your growth is our goal as we provide fact-based
analysis to assist you to enter, evolve, and expand in
emerginganddevelopedmarkets.Withourdiversebackground
covering research marketing, strategic planning and
management consulting, our role is reducing complexity
to help you maximise growth opportunities. We customise
each project to focus on your individual business objectives.
1Abbreviations
ASKES: Asuransi Kesehatan (previous health insurance
programe)
BP: Bukan Pekerja (informal sector, such as investors,
employers, retirees, etc)
PBPU: Pekerja Bukan Penerima Upah (informal sector who
are not paid by another party, such as entrepreneurs)
PPU: Pekerja Penerima Upah (formal sector paid by other
party, such as employees, civil servants, etc)
PBI: Penerima Bantuan Iuran (informal sector with low
ability to pay premiums who are supported by government
funds)
Ipsos Business Consulting Identifying Opportunities Within Asean’s Universal Healthcare Programmes | 11
12. GO-TO-MARKET
Preparing for market entry has never been so complex.
The rise of global connectivity, both online and in terms
of real-world trade infrastructure, means that businesses
need to adapt to rapid changes throughout the world of
commerce. New trade partnerships allow competition to
come from all sides, e-commerce requires a revolution in
logistics, and the rise of internet advertising demands
mastery of this new media platform.
These new market realities affect consumer preferences
intermsofproductsandtheirmethodofpurchase,advertising
models, logistics in an e-commerce world, legal requirements
at every step of the way, and competitors both local and
overseas. Companies must remain ready to respond to
real-time evaluations of sales performance, while continuing
to monitor progress toward long-term goals.
Now more than ever, a detailed understanding of the market
is an essential element of a winning business model. The
Ipsos Business Consulting proprietary model for Go-to-Market
strategy, combined with our world-class marketing research
service in 88 countries around the world, puts us ahead
of the pack in preparing our clients for the new realities
of the global marketplace.
Ipsos begins its Go-to-Market process with a detailed
assessment of the existing marketplace to identify its needs,
opportunities and limitations as well as the strengths and
weaknesses of competitors. We then provide a clear entry
strategy based on our clients’ products and their unique
selling points, identifying reliable local partners to assist
in market entry.
By determining market growth potential through a realistic
analysis of its drivers and barriers, Ipsos clearly maps the
businesslandscapetoshowthewayforward.Precisecustomer
demographic profiles identify your target market, while
a breakdown of your product value chain allows you to
optimise the logistics network from end to end.
This framework allows us to identify your company’s inherent
strengths, match each product to its ideal marketplace,
and position your brand for maximum impact. We help
you set realistic goals, whether your KPIs focus on growing
your market share, increasing penetration or finding a new
niche for your products. Ipsos’s own visual model to compare
pilot projects in terms of cost, timescale, ease of
implementation, and potential performance level, makes
deciding on strategy a straightforward process.
With the right plan in place, we map out a realistic timeline
for short, medium and long-term goals, as well as the means
to measure progress towards them. Ipsos continually does
duediligenceon potentialpartnershipswith otherbusinesses,
compiling easy-to-read comparative summaries that examine
severalkeyparametersinordertoidentifythemostpromising
among them.
Along the way, we continually seek out strategic levers your
company can use to gain a market advantage, and then we
convert them into clear initiatives for fast implementation.
Our Project Management Office provides you with status
reports and simple dashboards so that a current evaluation
of your progress is always at your fingertips.
Well-researched, comprehensive and easy to use: Our
dedicated multi-level approach makes Ipsos an ideal partner
for Go-to-Market in both emerging and developed markets.
For more information on how you can get started on the
path to market success, go to www.ipsosconsulting.com
to find your nearest office.
www.ipsosconsulting.com/go-to-market
EXPERIENCE OF GO-TO-MARKET
strategy in emerging and
developed markets
OVER
1
Market
Dynamics
2
Market
Diagnostics
3
Market
Assessment
4
Internal
Diagnostics
5
Market
Entry
6
Partner
Evaluation
7
Implementation
Our 7-stage
Go-to-Market
SOLUTION
20YEARS
13. ABOUT IPSOS BUSINESS CONSULTING
Ipsos Business Consulting is the specialist consulting
division of Ipsos, which is ranked third in the global research
industry. With a strong presence in 88 countries, Ipsos
employs more than 16,000 people.
We have the ability to conduct consulting engagements
in more than 100 countries. Our team of consultants has
been serving clients worldwide through our 21 consulting
"hubs" since 1994. Our suite of solutions has been developed
using over 20 years experience of working on winning sales
andmarketingstrategiesfordevelopedandemergingmarkets.
There is no substitute for first-hand knowledge when it
comes to understanding an industry. We draw on the detailed
industry expertise of our consultants, which has been
accumulated through practical project execution.
Founded in France in 1975, Ipsos is controlled and
managed by research and consulting professionals. They
have built a solid Group around a multi-specialist positioning.
Ipsos is listed on Eurolist - NYSE-Euronext. The company
is part of the SBF 120 and the Mid-60 index and is eligible
for the Deferred Settlement Service (SRD).ISIN code
FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP
Build · Compete · Grow
At Ipsos Business Consulting we focus on maintaining our
position as a leading provider of high quality consulting
solutions for sales and marketing professionals. We deliver
information, analysis and recommendations that allow our
clients to make smarter decisions and to develop and
implement winning market strategies.
We believe that our work is important. Security, simplicity,
speed and substance applies to everything we do.
Through specialisation, we offer our clients a unique depth
of knowledge and expertise. Learning from different
experiences gives us perspective and inspires us to boldly
call things into question, to be creative.
By nurturing a culture of collaboration and curiosity, we
attract the highest calibre of people who have the ability
and desire to influence and shape the future.
Our Solutions
· Go-to-Market · Market Sizing
· Business Unit Strategy · Pricing
· Competitive Intelligence · Forecasting
· Partner Evaluation · Brand Strategy & Value
· Innovation Scouting · Sales Detector
· Optimal Channel Strategy · B2B Customer
Segmentation
AUTHORS
Stevens Hendrajaya
Senior Consultant, Indonesia
E. Stevens.Hendrajaya@ipsos.com
T. +62 21 527 7701
Douglas Cassidy
Head of Consulting, Indonesia
E. Douglas.Cassidy@ipsos.com
T. +62 21 527 7701
Xiaobo Cui
Global Healthcare Sector Lead
E. Xiaobo.Cui@ipsos.com
T. +86 10 52193224
14. CONTACT US
healthcare.bc@ipsos.com www.ipsosconsulting.com Ipsos Business Consulting
AUSTRALIA
Level 13, 168 Walker Street
North Sydney 2060
NSW, Australia
E. australia.bc@ipsos.com
T. 61 (2) 9900 5100
GREATER CHINA
BEIJING
12th Floor, Union Plaza
No. 20 Chao Wai Avenue
Chaoyang District, 100020
Beijing, China
E. china.bc@ipsos.com
T. 86 (10) 5219 8899
SHANGHAI
31/F Westgate Mall
1038 West Nanjing Road 200041
Shanghai, China
E. china.bc@ipsos.com
T. 86 (21) 2231 9988
WUHAN
10F HongKong & Macao Center
118JiangHan Road
HanKou Wuhan, 430014
Wuhan, China
E. china.bc@ipsos.com
T. 86 (27) 5988 5888
HONG KONG
22/F Leighton Centre
No 77 Leighton Road
Causeway Bay
Hong Kong
E. hongkong.bc@ipsos.com
T. 852 3766 2288
INDIA
MUMBAI
Lotus Corporate Park
1701, 17th Floor, F Wing
Off Western Express Highway
Goregoan (E),
Mumbai – 400063, India
E. india.bc@ipsos.com
T. 91 (22) 6620 8000
GURGAON
801, 8th Floor, Vipul Square
B-Block, Sushant Lok, Part-1
Gurgaon – 122016, Haryana,
India
E. india.bc@ipsos.com
T. 91 (12) 4469 2400
INDONESIA
Graha Arda, 3rd Floor
Jl. H.R. Rasuna Said Kav B-6, 12910
Kuningan
Jakarta, Indonesia
E. indonesia.bc@ipsos.com
T. 62 (21) 527 7701
JAPAN
Hulic Kamiyacho Building
4-3-13, Toranomon
Minato-ku, 105-0001
Tokyo, Japan
E. japan.bc@ipsos.com
T. 81 (3) 6867 8001
KENYA
Acorn House
97 James Gichuru Road Lavington
P.O. Box 68230
00200 City Square
Nairobi, Kenya
E. africa.bc@ipsos.com
T. 254 (20) 386 2721-33
MALAYSIA
18th Floor, Menara IGB
No. 2 The Boulevard
Mid Valley City
Lingkaran Syed Putra, 59200
Kuala Lumpur, Malaysia
E. malaysia.bc@ipsos.com
T. 6 (03) 2282 2244
NIGERIA
Block A, Obi Village
Opposite Forte Oil
MM2 Airport Road, Ikeja
Lagos, Nigeria
E. africa.bc@ipsos.com
T. 234 (806) 629 9805
PHILIPPINES
1401-B, One Corporate Centre
Julia Vargas cor. Meralco Ave
Ortigas Center, Pasig City, 1605
Metro Manila, Philippines
E. philippines.bc@ipsos.com
T. 63 (2) 633 3997
SINGAPORE
3 Killiney Road #05-01
Winsland House I, S239519
Singapore
E. singapore.bc@ipsos.com
T. 65 6333 1511
SOUTH AFRICA
Wrigley Field The Campus
57 Sloane Street Bryanston
Johannesburg, South Africa
E. africa.bc@ipsos.com
T. 27 (11) 709 7800
SOUTH KOREA
12th Floor, Korea Economic
Daily Building, 463 Cheongpa-Ro
Jung-Gu 100-791
Seoul, South Korea
E. korea.bc@ipsos.com
T. 82 (2) 6464 5100
THAILAND
21st and 22nd Floor, Asia Centre Building
173 Sathorn Road South
Khwaeng Tungmahamek
Khet Sathorn 10120
Bangkok, Thailand
E. thailand.bc@ipsos.com
T. 66 (2) 697 0100
UAE
4th Floor, Office No 403
Al Thuraya Tower 1
P.O. Box 500611
Dubai Media City, UAE
E. uae.bc@ipsos.com
T. 971 (4) 4408 980
UK
3 Thomas More Square
London E1 1YW
United Kingdom
E. europe.bc@ipsos.com
T. 44 (20) 3059 5000
USA
Time & Life Building
1271 Avenue of the Americas
15th Floor
New York, NY10020
United States of America
E. us.bc@ipsos.com
T. 1 (212) 265 3200
VIETNAM
Level 9A, Nam A Bank Tower
201-203 CMT8 Street, Ward 4
District 3
HCMC, Vietnam
E. vietnam.bc@ipsos.com
T. 84 12646 84 714